View in EDS

A real-world study assessing the efficacy and safety of switching from basal bolus insulin therapy to once daily iGlarLixi in people with type 2 diabetes mellitus: soli de-escalation.

Saved in:
Bibliographic Details
Title: A real-world study assessing the efficacy and safety of switching from basal bolus insulin therapy to once daily iGlarLixi in people with type 2 diabetes mellitus: soli de-escalation.
Authors: Giorgino, Francesco1 (AUTHOR) francesco.giorgino@uniba.it, Taybani, Zoltán2 (AUTHOR), Cheng, Alice3 (AUTHOR), Tebaibia, Amar4 (AUTHOR), Anaforoglu, İnan5 (AUTHOR), Lauand, Felipe6 (AUTHOR), Servera, Soraly7 (AUTHOR), Li, Xuan1,7 (AUTHOR), Fonseca, Vivian8 (AUTHOR)
Source: Diabetes Research & Clinical Practice. Nov2025, Vol. 229, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:01688227
DOI:10.1016/j.diabres.2025.112945